Tenofovir Alafenamide
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4180 publications
A precautionary tale of lenacapavir drug-drug interactions: A case series of two persons living with HIV receiving long-acting injections.
Journal: International journal of STD & AIDS
Published: June 18, 2026
Hepatitis B in pregnancy and breastfeeding: current approaches to prophylaxis and treatment.
Journal: Expert review of anti-infective therapy
Published: June 16, 2026
Updating "A nationally representative dataset of 1549 Americans aged 18 to 94 on interest in, experience with, and barriers to cogeneration, defined as working with older and younger people for social good" with data on religious identity and service attendance.
Journal: Data in brief
Published: June 01, 2026
Metallic 1T NaxMoS2 as Sulfur Host for Room Temperature Na-S Batteries.
Journal: ACS nano
Published: May 20, 2026
Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Towards Functional Cure or a Marginal Margin? Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: May 15, 2026
Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Toward Functional Cure or a Marginal Margin?
Journal: Alimentary pharmacology & therapeutics
Published: May 10, 2026
The NMR Exchange Format (NEF): Specification and Applications.
Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026
Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.
Journal: Nature communications
Published: April 27, 2026
Incident Hypertension with Antiretroviral Therapy in the OPERA Cohort.
Journal: Journal of the International Association of Providers of AIDS Care
Published: April 23, 2026
Integrated Redox Profiling: Simultaneous Determination of Ubiquinol-10, Ubiquinone-10, and Alpha-Lipoic Acid in Serum by LC-MS/MS.
Journal: Metabolites
Published: April 22, 2026
The protease inhibitor darunavir prevents esophagitis and impairments in esophageal barrier function in a mouse model of GERD.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: April 21, 2026
Last Updated: 06/30/2026